References
- Swerdlow SH, Campo E, Harris NL, . WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC; 2008.
- Yamashita Y, Yatabe Y, Tsuzuki T, . Perforin and granzyme expression in cytotoxic T-cell lymphomas. Mod Pathol 1998;11:313–323.
- Willemze R, Jaffe ES, Burg G, . WHO-EORTC classification for cutaneous lymphomas. Blood 2005;105:3768–3785.
- Martinez A, Ponzoni M, Agostinelli C. Primary bone marrow lymphoma: an uncommon extranodal presentation of aggressive non-Hodgkin lymphomas. Am J Surg Pathol 2012;36:296–304.
- Szomor A, Saati TA, Delsol G, . Primary bone marrow T-cell anaplastic large cell lymphoma with triple M gradient. Pathol Oncol Res 2007;13:260–262.
- Gudgin E, Rashbass J, Pulford KJ, . Primary and isolated anaplastic large cell lymphoma of the bone marrow. Leuk Lymphoma 2005;46:461–463.
- Greer JP, Kinney MC, Collins RD, . Clinical features of 31 patients with Ki-1 anaplastic large-cell lymphoma. J Clin Oncol 1991;9:539–547.
- Blakolmer K, Vesely M, Kummer JA, . Immunoreactivity of B-cell markers (CD79a, L26) in rare cases of extranodal cytotoxic peripheral T- (NK/T-) cell lymphomas. Mod Pathol 2000;13:766–772.
- Rahemtullah A, Longtine JA, Harris NL, . CD20+T-cell lymphoma: clinicopathologic analysis of 9 cases and a review of the literature. Am J Surg Pathol 2008;32:1593–1607.
- Quintanilla-Martinez L, Preffer F, Rubin D, . CD20 + T-cell lymphoma: neoplastic transformation of a normal T-cell subset. Am J Clinical Pathol 1994;102:483–489.
- Hultin LE, Hausner MA, Hultin PM, . CD20 (pan-B cell antigen) is expressed at low level on a subpopulation of human T lymphocytes. Cytometry 1993;14:196–204.
- Buckner CL, Christiansen LR, Burgeois D, . CD20 positive T-cell lymphoma/leukemia: a rare entity with potential diagnostic pitfalls. Ann Clin Lab Sci 2007;37:263–267.
- Hirata Y, Yokote T, Kobayashi K, . Rituximab for the treatment of CD20-positive peripheral T-cell lymphoma, unspecified. Leuk Res 2009;33:e13–e16.
- Rothenberg EV, Taghon T. Molecular genetics of T cell development. Annu Rev Immunol 2005;23:601–649.
- Yasutomo K, Doyle C, Miele L, . The duration of antigen receptor signalling determines CD4+ versus CD8+ T-cell lineage fate. Nature 2005;404:506–510.
- De Level L, Gaulard P. Pathology and biology of peripheral T-cell lymphomas. Histopathology 2011;58:49–68.